R
R.M. Rabanal
Researcher at Autonomous University of Barcelona
Publications - 45
Citations - 1496
R.M. Rabanal is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Antigen & Versican. The author has an hindex of 19, co-authored 44 publications receiving 1363 citations.
Papers
More filters
Journal ArticleDOI
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano,Paloma Martinez-Redondo,Anna Marazuela-Duque,Berta N. Vazquez,Scott J. Dooley,Philipp Voigt,David B. Beck,Noriko Kane-Goldsmith,Qiang Tong,R.M. Rabanal,Dolors Fondevila,Purificación Muñoz,Marcus Krüger,Jay A. Tischfield,Alejandro Vaquero +14 more
TL;DR: It is shown that SirT2 regulates H4K20me1 deposition through the deacetylation of H 4K16Ac and determines the levels of H4 k20me2/3 throughout the cell cycle and upon stress, the interaction betweenSirT2 and PR-Set7 increases along with the H4k20me 1 levels, suggesting a novel mitotic checkpoint mechanism.
Journal ArticleDOI
Pathologic and Immunocytochemical Studies of Morbillivirus Infection in Striped Dolphins (Stenella coeruleoalba)
TL;DR: Histologically, a bronchiolo-interstitial pneumonia was the most frequent lesion and encephalitis due to Aspergillus fumigatus were seen in three dolphins, whereas two animals had lesions of toxoplasmosis.
Journal ArticleDOI
Identification of Leishmania donovani amastigotes in canine tissues by immunoperoxidase staining.
TL;DR: This paper describes the demonstration of Leishmania donovani amastigotes in canine tissues by immunoperoxidase staining and allows unequivocal histopathological diagnosis of canine leishmaniasis.
Journal ArticleDOI
Skin lesions in canine leishmaniasis
TL;DR: Forty-three dogs affected by canine leishmaniasis with skin lesions have been studied clinically and histopathologically and the possible pathogenesis and the differential diagnosis of each form is discussed.
Journal ArticleDOI
Canine mast cell tumors express stem cell factor receptor.
TL;DR: KIT can be used as a reliable immunohistochemical marker for canine mast cells and undifferentiated mast cell tumors and there is an inverse correlation between the degree of differentiation and the expression of KIT.